These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 8552404

  • 41. Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.
    Chmara M, Wozniak A, Ochman K, Kobierska G, Dziadziuszko R, Sosinska-Mielcarek K, Jassem E, Skokowski J, Jassem J, Limon J.
    Anticancer Res; 2004; 24(6):4259-63. PubMed ID: 15736482
    [Abstract] [Full Text] [Related]

  • 42. Allelotype of non-small cell lung carcinoma--comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma.
    Tsuchiya E, Nakamura Y, Weng SY, Nakagawa K, Tsuchiya S, Sugano H, Kitagawa T.
    Cancer Res; 1992 May 01; 52(9):2478-81. PubMed ID: 1314694
    [Abstract] [Full Text] [Related]

  • 43. Localization of a novel tumor suppressor gene loci on chromosome 9p21-22 in oral cancer.
    Nakanishi H, Wang XL, Imai FL, Kato J, Shiiba M, Miya T, Imai Y, Tanzawa H.
    Anticancer Res; 1999 May 01; 19(1A):29-34. PubMed ID: 10226521
    [Abstract] [Full Text] [Related]

  • 44. Deletion mapping of chromosome 2 in human lung carcinoma.
    Otsuka T, Kohno T, Mori M, Noguchi M, Hirohashi S, Yokota J.
    Genes Chromosomes Cancer; 1996 Jun 01; 16(2):113-9. PubMed ID: 8818658
    [Abstract] [Full Text] [Related]

  • 45. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC).
    Schmid M, Malicki D, Nobori T, Rosenbach MD, Campbell K, Carson DA, Carrera CJ.
    Oncogene; 1998 Nov 19; 17(20):2669-75. PubMed ID: 9840931
    [Abstract] [Full Text] [Related]

  • 46. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Garinis GA, Gorgoulis VG, Mariatos G, Zacharatos P, Kotsinas A, Liloglou T, Foukas P, Kanavaros P, Kastrinakis NG, Vassilakopoulos T, Vogiatzi T, Field JK, Kittas C.
    J Pathol; 2001 Jan 19; 193(1):55-65. PubMed ID: 11169516
    [Abstract] [Full Text] [Related]

  • 47. Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer.
    Fong KM, Zimmerman PV, Smith PJ.
    Cancer Res; 1995 Jan 15; 55(2):220-3. PubMed ID: 7812947
    [Abstract] [Full Text] [Related]

  • 48. Loss of heterozygosity affecting the APC and MCC genetic loci in patients with primary breast carcinomas.
    Medeiros AC, Nagai MA, Neto MM, Brentani RR.
    Cancer Epidemiol Biomarkers Prev; 1994 Jun 15; 3(4):331-3. PubMed ID: 8061582
    [Abstract] [Full Text] [Related]

  • 49. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI, Minna JD.
    Cancer Res; 2000 Nov 01; 60(21):6116-33. PubMed ID: 11085536
    [Abstract] [Full Text] [Related]

  • 50. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
    Spanakis NE, Gorgoulis V, Mariatos G, Zacharatos P, Kotsinas A, Garinis G, Trigidou R, Karameris A, Tsimara-Papastamatiou H, Kouloukousa M, Manolis EN, Kittas C.
    Anticancer Res; 1999 Nov 01; 19(3A):1893-9. PubMed ID: 10470133
    [Abstract] [Full Text] [Related]

  • 51. LOH at the APC/MCC gene (5Q21) is frequent in early stages of non-small cell lung cancer.
    Sanz-Ortega J, Bryant B, Sanz-Esponera J, Asenjo JA, Saez MC, Torres A, Balibrea JL, Sobel ME, Merino MJ.
    Pathol Res Pract; 1999 Nov 01; 195(10):677-80. PubMed ID: 10549031
    [Abstract] [Full Text] [Related]

  • 52. Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma.
    Shivapurkar N, Virmani AK, Wistuba II, Milchgrub S, Mackay B, Minna JD, Gazdar AF.
    Clin Cancer Res; 1999 Jan 01; 5(1):17-23. PubMed ID: 9918198
    [Abstract] [Full Text] [Related]

  • 53. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D, Gutiérrez JA, Rosenblum ML, Newsham IF, Bögler O, Rempel SA, NABTT CNS Consortium.
    Clin Cancer Res; 2003 Oct 01; 9(12):4435-42. PubMed ID: 14555516
    [Abstract] [Full Text] [Related]

  • 54. Comparative allelotype of early and advanced stage non-small cell lung carcinomas.
    Shiseki M, Kohno T, Adachi J, Okazaki T, Otsuka T, Mizoguchi H, Noguchi M, Hirohashi S, Yokota J.
    Genes Chromosomes Cancer; 1996 Oct 01; 17(2):71-7. PubMed ID: 8913723
    [Abstract] [Full Text] [Related]

  • 55. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.
    Konishi H, Sugiyama M, Mizuno K, Saito H, Yatabe Y, Takahashi T, Osada H, Takahashi T.
    Oncogene; 2003 Mar 27; 22(12):1892-905. PubMed ID: 12660825
    [Abstract] [Full Text] [Related]

  • 56. Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1.
    Yokota T, Yoshimoto M, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y, Emi M.
    Cancer; 1999 Jan 15; 85(2):447-52. PubMed ID: 10023714
    [Abstract] [Full Text] [Related]

  • 57. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.
    Marsit CJ, Hasegawa M, Hirao T, Kim DH, Aldape K, Hinds PW, Wiencke JK, Nelson HH, Kelsey KT.
    Cancer Res; 2004 Dec 01; 64(23):8702-7. PubMed ID: 15574780
    [Abstract] [Full Text] [Related]

  • 58. [Fine deletion mapping on chromosome 8p21 - 8p22 in adenocarcinoma of lung].
    Shao S, Sun W, Zhang J, An Q, Xiao T, Yang P, Cheng S, Gao Y.
    Zhonghua Yi Xue Za Zhi; 2002 Jun 10; 82(11):740-2. PubMed ID: 12126542
    [Abstract] [Full Text] [Related]

  • 59. Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kb.
    Bell SM, Zuo J, Myers RM, Knowles MA.
    Genes Chromosomes Cancer; 1996 Oct 10; 17(2):108-17. PubMed ID: 8913728
    [Abstract] [Full Text] [Related]

  • 60. Identification of two distinct tumor-suppressor loci on the long arm of chromosome 10 in small cell lung cancer.
    Kim SK, Ro JY, Kemp BL, Lee JS, Kwon TJ, Hong WK, Mao L.
    Oncogene; 1998 Oct 01; 17(13):1749-53. PubMed ID: 9796705
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.